Live Events

This Beginner Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) Course is designed for physical therapists, physicians, and advanced practice providers who care for pediatric bleeding disorder patients seeking to develop foundational skills in ultrasound with a focus on musculoskeletal assessment and joint pathology using the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol. Over two and a half days, participants will engage in a combination of didactic lectures, hands-on scanning practice, and interactive case discussions to reinforce key ultrasound principles. The curriculum covers ultrasound physics, equipment optimization, normal joint anatomy, and scanning techniques for the elbow, knee, and ankle using the HEAD-US protocol. Participants will also gain experience in recognizing common pathological findings, including osteochondral damage, acute hemarthrosis and joint recess distension by effusion and synovial proliferation. Finally, the course also introduces key considerations for musculoskeletal imaging in children and a concise overview of HEAD-US scoring of hemophilic arthropathy, aspects that will be explored in-depth in the advanced course. Join us for a specialized training experience led by Drs. Carlo Martinoli, Nihal Bakeer, and Kyle Davis, along with the highly experienced physicians and physical therapists at Innovative Hematology. This course focuses on foundational skills (Level I) and does not cover advanced topics, such as muscle injuries, advanced pediatric arthropathy detection, or HEAD-US scoring calibration. For those interested in these advanced topics, we offer a separate advanced course.

At the conclusion of this live activity, participants should be better able to:

• Develop fundamental ultrasound skills
  • Understand the principles of ultrasound physics, equipment adjustment, and scanning techniques to accurately assess musculoskeletal structures.
• Perform systematic joint ultrasound examinations
  • Acquire proficiency in the HEAD-US protocol, including anatomical review and hands-on scanning of the elbow, knee, and ankle in person with and without hemophilia, all under expert guidance.
• Identify normal and pathological findings
  • Recognize normal joint anatomy and interpret key pathological ultrasound findings, including synovial changes, hemarthrosis, and osteochondral surface abnormalities.
• Gain basic understanding of pediatric ultrasound scanning and HEAD-US scoring
  • Learn the anatomical nuances of the immature skeleton and key considerations for musculoskeletal imaging in children.
  • Develop a basic understanding of the HEAD-US scoring system for hemophilia arthropathy in this age group.

*Objectives subject to change

Physical therapists, physicians, and advance practice providers who currently are, and have been, working at a Hemophilia Treatment Center (HTC) for at least six (6) months.

Continuing education units (CEUs) will be offered through the California Physical Therapy Association (CPTA).

Review the Course Comparison Chart/Eligibility Criteria to determine your eligibility before submitting your application. Please note, eligibility for the course does not guarantee a spot at the program or that your applicable will be accepted. Please follow application instructions.

To attend the Beginner Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) course, you must meet the following criteria:

• Be employed at a Hemophilia Treatment Center (HTC) in a bleeding disorder patient-facing role for at least six (6) months.
• Provide care to pediatric patients. Lifespan providers are also eligible to apply.
• Have access to a point-of-care MSKUS device at HTC place of employment.
• Work at an HTC that intends to have dedicated staff to perform MSKUS.
• While beneficial, no prior MSKUS experience is required for this course.

Unlike other Partners Programs, you must submit an application for the course to be reviewed by a selection committee; submission of an application does not guarantee your enrollment in the course. Upon review by the Selection Committee, you will be notified via email regarding your admission status. In the meantime, if you have any questions, you may contact partners@inheme.org

• Applications are accepted through March 31, 2026 at 11:59 pm Eastern. Incomplete and/or late applications will not be considered.
• Please allow adequate time prior to submission for completion of the required Letter of Support from your HTC Director/Supervisor. HTC Director/Supervisor Letter of Support Writing Guidance.
• The application is designed to obtain information about your experience in bleeding disorders and musculoskeletal ultrasound to date. Please answer each question to the best of your ability, as this is your opportunity for the Selection Committee to get to know you, your background, and your experience.
• Apply Now

• There is no registration fee to attend a Partners Program.
• Accepted applicants will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All applicants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Programs are supported by education grant(s) from the following entities: Cascade Hemophilia Consortium; Sanofi; Genentech, a member of the Roche Group; Pfizer; and the Indiana Hemophilia & Thrombosis Center (IHTC).

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• August 3-5, 2026

Apply Now

This Advanced Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) Course is designed for physical therapists, physicians, and advanced practice providers with prior ultrasound experience seeking to enhance their skills in comprehensive pediatric joint assessment, muscle injury evaluation, and scoring of hemophilic arthropathy using the Hemophilic Arthropathy Early Detection with Ultrasound (HEAD-US) protocol. This intensive two-day course provides an in-depth review of ultrasound techniques used for imaging both healthy and affected pediatric joints (elbows, knees, and ankles), with a focus on advanced pathology detection and practical hands-on sessions under expert tutoring. Participants will refine their expertise in HEAD-US scoring, engage in live-case scanning and scoring, and undergo self-testing calibration exercises on a large dataset of scans. Additional sessions will address synovial and osteochondral mimickers, image interpretation pitfalls, and guidelines for acquiring standardized imaging documentation for external reading. Through expert-led interactive sessions, attendees will gain confidence to apply advanced ultrasound techniques into clinical practice. Join us for a unique training experience led by Drs. Carlo Martinoli, Nihal Bakeer, and Kyle Davis, along with the highly experienced physicians and physical therapists at Innovative Hematology.

At the conclusion of this live activity, participants should be better able to:

• Master advanced pediatric MSK and joint ultrasound scanning
  • Gain proficiency in ultrasound scanning of both healthy and arthropathic pediatric joints and in accurate image interpretation through deep understanding of pediatric skeletal maturation as well as imaging pitfalls and nuances. Practical sessions will incorporate "tips and tricks" to consolidate knowledge and enhance scanning confidence.
• Enhance interpretation and scoring skills using HEAD-US
  • Deepen understanding of the HEAD-US scoring system through structured calibration exercises, live case scanning, and real-time scoring to improve diagnostic accuracy and interobserver reliability.
• Recognize and interpret advanced pathological findings
  • Identify and differentiate key pathological ultrasound findings in pediatric joints and muscles, including synovial hypertrophy, hemarthrosis, osteochondral changes, and muscle hematomas. Differential diagnoses will be described to avoid misinterpretation and support accurate clinical assessment.

*Objectives subject to change

Physical therapists, physicians, and advance practice providers who currently are, and have been, working at a Hemophilia Treatment Center (HTC) for at least six (6) months.

Continuing education units (CEUs) will be offered through the California Physical Therapy Association (CPTA).

Review the Course Comparison Chart/Eligibility Criteria to determine your eligibility before submitting your application. Please note, eligibility for the course does not guarantee a spot at the program or that your applicable will be accepted. Please follow application instructions.

To attend the Beginner Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) course, you must meet the following criteria:

• Be employed at a Hemophilia Treatment Center (HTC) in a bleeding disorder patient-facing role for at least six (6) months.
• Provide care to pediatric patients. Lifespan providers are also eligible to apply.
• Have access to a point-of-care MSKUS device at HTC place of employment.
• Work at an HTC that intends to have dedicated staff to perform MSKUS.
• Need to have demonstrated proficiency scanning patients using point-of-care ultrasound and be able to identify normal joint anatomy in ultrasound scanning planes.
• Prior MSKUS experience is required for this course.

Unlike other Partners Programs, you must submit an application for the course to be reviewed by a selection committee; submission of an application does not guarantee your enrollment in the course. Upon review by the Selection Committee, you will be notified via email regarding your admission status. In the meantime, if you have any questions, you may contact partners@inheme.org

• Applications are accepted through March 31, 2026 at 11:59 pm Eastern. Incomplete and/or late applications will not be considered.
• Please allow adequate time prior to submission for completion of the required Letter of Support from your HTC Director/Supervisor. HTC Director/Supervisor Letter of Support Writing Guidance.
• The application is designed to obtain information about your experience in bleeding disorders and musculoskeletal ultrasound to date. Please answer each question to the best of your ability, as this is your opportunity for the Selection Committee to get to know you, your background, and your experience.
• Apply Now

• There is no registration fee to attend a Partners Program.
• Accepted applicants will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All applicants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Programs are supported by education grant(s) from the following entities: Cascade Hemophilia Consortium; Sanofi; Genentech, a member of the Roche Group; Pfizer; and the Indiana Hemophilia & Thrombosis Center (IHTC).

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• August 6-7, 2026

Apply Now

The Basic Partners Program for Social Workers is intended to enable participants, psychosocial professionals engaged as core team members of the multidisciplinary hemophilia comprehensive care team, to develop knowledge and competence to provide high quality psychosocial care for persons with bleeding disorders.

At the conclusion of this live activity, the participants should be better able to:

• Discuss the expanded role of the social worker in the multidisciplinary comprehensive care team
• Articulate characteristics of hemophilia including its genetics, pathophysiology, complications, treatment, and psychosocial impact
• Identify ways to improve skills in the assessment and management of hemophilia and its complications surrounding psychosocial issues of coping, adherence, and quality of life
• Foster a culturally sensitive, family-centered approach to care
• Recognize the value of a professional mentoring network within the federally recognized U.S. Hemophilia Treatment Center (HTC) network

Social workers and other psychosocial professionals who currently are and have been caring for persons with bleeding disorders in the federally recognized U.S. Hemophilia Treatment Center (HTC) network for at least six (6) months.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Social work continuing education credits will be provided.

To attend this program, you must meet the following criteria:

• Be employed at a U.S federally recognized HTC in a bleeding disorder patient-facing role for at least six (6) months.
• Obtain approval to attend from Regional Administrator via automated process upon submission of application.
  • Apply for this program by completing the Application Form.
  • Apply Now

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the  Partners Travel Policy to understand costs that are covered and costs that you may incur.
• The Partners in Bleeding Disorders Education Program is supported by an independent medical education grant(s). Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia & Thrombosis Center.

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• August 24-26, 2026

Apply Now